Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 311,405
  • Shares Outstanding, K 182,108
  • Annual Sales, $ 1,640 K
  • Annual Income, $ -16,440 K
  • 60-Month Beta -5.81
  • Price/Sales 195.67
  • Price/Cash Flow N/A
  • Price/Book 3.29
Trade IBIO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/13
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0300 +67.48%
on 12/31/20
1.8700 -7.75%
on 01/13/21
+0.5650 (+48.71%)
since 12/24/20
3-Month
1.0300 +67.48%
on 12/31/20
2.1100 -18.25%
on 11/16/20
-0.1250 (-6.76%)
since 10/26/20
52-Week
0.2302 +649.35%
on 01/30/20
7.4500 -76.85%
on 07/21/20
+1.4460 (+518.28%)
since 01/24/20

Most Recent Stories

More News
Immunotherapy Using Immune-Checkpoint Inhibitors (ICI) Modulators Are Revolutionizing Oncology Industry

, /PRNewswire/ -- Ovarian cancer is one of the most deadly gynecologic malignancy across the globe, but new treatments are gaining increased efficacy while displaying reduced toxicity. Clinical trials...

BIOV.CN : 0.370 (+1.37%)
LMNGF : 0.2902 (+4.65%)
VBLT : 2.71 (-6.87%)
IBIO : 1.7200 (+0.58%)
INFI : 3.84 (-2.78%)
ADMP : 1.6450 (-4.36%)
Thinking about buying stock in iBio, Fluidigm Corp, Atossa Therapeutics, BioCryst Pharmaceuticals, or GameStop?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, FLDM, ATOS, BCRX, and GME.

IBIO : 1.7200 (+0.58%)
BCRX : 9.14 (-0.22%)
FLDM : 6.53 (-3.55%)
ATOS : 2.43 (-18.46%)
GME : 148.78 (+93.75%)
Thinking about buying stock in iBio, Plug Power, Canoo, Gevo, or Biolase?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, PLUG, GOEV, GEVO, and BIOL.

IBIO : 1.7200 (+0.58%)
GOEV : 16.12 (-4.05%)
BIOL : 1.4400 (+38.46%)
GEVO : 12.56 (-5.14%)
PLUG : 73.71 (+12.16%)
iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced the appointment of Martin B. Brenner, DVM, Ph.D., as its Chief...

IBIO : 1.7200 (+0.58%)
Thinking about buying stock in Nantkwest, Ampio Pharmaceuticals, Arbutus Biopharma, Xeris Pharmaceuticals, or iBio Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NK, AMPE, ABUS, XERS, and IBIO.

AMPE : 1.6800 (-3.45%)
IBIO : 1.7200 (+0.58%)
ABUS : 3.83 (-4.49%)
NK : 19.24 (+1.21%)
XERS : 5.47 (-2.32%)
iBio Announces Closing of its Public Offering of Common Stock

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced the closing of its underwritten public offering of approximately...

IBIO : 1.7200 (+0.58%)
Thinking about buying stock in Sundial Growers, iBio, Cinedigm Corp, AMC Entertainment, or HollySys Automation?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, IBIO, CIDM, AMC, and HOLI.

AC : 35.14 (+0.40%)
IBIO : 1.7200 (+0.58%)
CIDM : 1.3850 (-2.46%)
HOLI : 14.18 (-3.27%)
SNDL : 0.5586 (-6.90%)
AMC : 4.86 (+9.95%)
iBio Announces Pricing of $35 Million Public Offering of Common Stock

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced the pricing of its underwritten public offering of approximately...

IBIO : 1.7200 (+0.58%)
iBio Announces Proposed Public Offering of Common Stock

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced an underwritten public offering of its common stock. In addition,...

IBIO : 1.7200 (+0.58%)
Development of Advanced Novel AML Drugs Target Increasing Cases of Acute Myeloid Leukemia

PALM BEACH,  Fla., /PRNewswire/ -- Acute myeloid leukemia (AML) is a rare and heterogeneous blood cancer with a poor overall prognosis. It affects predominantly older adults with a median age at diagnosis...

MBRX : 1.0350 (-0.48%)
IBIO : 1.7200 (+0.58%)
MACK : 7.51 (-0.53%)
CATB : 2.65 (-3.64%)
AZN : 54.49 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture...

See More

Key Turning Points

3rd Resistance Point 2.0067
2nd Resistance Point 1.9033
1st Resistance Point 1.8067
Last Price 1.7200
1st Support Level 1.6067
2nd Support Level 1.5033
3rd Support Level 1.4067

See More

52-Week High 7.4500
Fibonacci 61.8% 4.6920
Fibonacci 50% 3.8401
Fibonacci 38.2% 2.9882
Last Price 1.7200
52-Week Low 0.2302

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar